Cushing Syndrome Market 2024-2028

Report
144 Pages
October 2023
Region: Global
TechNavio
ID: 5896221

The cushing syndrome market is forecasted to grow by USD 616.66 mn during 2023-2028, accelerating at a CAGR of 14.7% during the forecast period. The report on the cushing syndrome market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, rising drug development for cushing syndrome treatment, and favorable reimbursement scenario of cushing syndrome treatment.

The cushing syndrome market is segmented as below:

By Type

Glucocorticoid receptor antagonists
Pituitary directed drugs
Steroidogenesis inhibitors

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rise in incidence of cushing syndrome as one of the prime reasons driving the cushing syndrome market growth during the next few years. Also, increasing growth potential in emerging economies and use of biosimilars for cushing syndrome treatment will lead to sizable demand in the market.

The report on the cushing syndrome market covers the following areas:

Cushing syndrome market sizing
Cushing syndrome market forecast
Cushing syndrome market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cushing syndrome market vendors that include Corcept Therapeutics Inc., Perrigo Co. Plc, Recordati S.p.A, and Xeris Biopharma Holdings Inc.. Also, the cushing syndrome market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Cushing syndrome market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global cushing syndrome market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Glucocorticoid receptor antagonists - Market size and forecast 2023-2028
Exhibit 34: Chart on Glucocorticoid receptor antagonists - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Glucocorticoid receptor antagonists - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Glucocorticoid receptor antagonists - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Glucocorticoid receptor antagonists - Year-over-year growth 2023-2028 (%)
6.4 Pituitary directed drugs - Market size and forecast 2023-2028
Exhibit 38: Chart on Pituitary directed drugs - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Pituitary directed drugs - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Pituitary directed drugs - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Pituitary directed drugs - Year-over-year growth 2023-2028 (%)
6.5 Steroidogenesis inhibitors - Market size and forecast 2023-2028
Exhibit 42: Chart on Steroidogenesis inhibitors - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Steroidogenesis inhibitors - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Steroidogenesis inhibitors - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Steroidogenesis inhibitors - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ million)
Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 50: Chart on Comparison by Distribution Channel
Exhibit 51: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2023-2028
Exhibit 52: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacy - Market size and forecast 2023-2028
Exhibit 56: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacy - Market size and forecast 2023-2028
Exhibit 60: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ million)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Corcept Therapeutics Inc.
Exhibit 115: Corcept Therapeutics Inc. - Overview
Exhibit 116: Corcept Therapeutics Inc. - Product / Service
Exhibit 117: Corcept Therapeutics Inc. - Key offerings
12.4 Perrigo Co. Plc
Exhibit 118: Perrigo Co. Plc - Overview
Exhibit 119: Perrigo Co. Plc - Business segments
Exhibit 120: Perrigo Co. Plc - Key news
Exhibit 121: Perrigo Co. Plc - Key offerings
Exhibit 122: Perrigo Co. Plc - Segment focus
12.5 Recordati S.p.A
Exhibit 123: Recordati S.p.A - Overview
Exhibit 124: Recordati S.p.A - Business segments
Exhibit 125: Recordati S.p.A - Key offerings
Exhibit 126: Recordati S.p.A - Segment focus
12.6 Xeris Biopharma Holdings Inc.
Exhibit 127: Xeris Biopharma Holdings Inc. - Overview
Exhibit 128: Xeris Biopharma Holdings Inc. - Product / Service
Exhibit 129: Xeris Biopharma Holdings Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 130: Inclusions checklist
Exhibit 131: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 132: Currency conversion rates for US$
13.4 Research methodology
Exhibit 133: Research methodology
Exhibit 134: Validation techniques employed for market sizing
Exhibit 135: Information sources
13.5 List of abbreviations
Exhibit 136: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global cushing syndrome market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Glucocorticoid receptor antagonists - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Glucocorticoid receptor antagonists - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Glucocorticoid receptor antagonists - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Glucocorticoid receptor antagonists - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Pituitary directed drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Pituitary directed drugs - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Pituitary directed drugs - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Pituitary directed drugs - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Steroidogenesis inhibitors - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Steroidogenesis inhibitors - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Steroidogenesis inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Steroidogenesis inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Type ($ million)
Exhibits 47: Data Table on Market opportunity by Type ($ million)
Exhibits 48: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 49: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Distribution Channel
Exhibits 51: Data Table on Comparison by Distribution Channel
Exhibits 52: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 64: Market opportunity by Distribution Channel ($ million)
Exhibits 65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2023 and 2028
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: Corcept Therapeutics Inc. - Overview
Exhibits 116: Corcept Therapeutics Inc. - Product / Service
Exhibits 117: Corcept Therapeutics Inc. - Key offerings
Exhibits 118: Perrigo Co. Plc - Overview
Exhibits 119: Perrigo Co. Plc - Business segments
Exhibits 120: Perrigo Co. Plc - Key news
Exhibits 121: Perrigo Co. Plc - Key offerings
Exhibits 122: Perrigo Co. Plc - Segment focus
Exhibits 123: Recordati S.p.A - Overview
Exhibits 124: Recordati S.p.A - Business segments
Exhibits 125: Recordati S.p.A - Key offerings
Exhibits 126: Recordati S.p.A - Segment focus
Exhibits 127: Xeris Biopharma Holdings Inc. - Overview
Exhibits 128: Xeris Biopharma Holdings Inc. - Product / Service
Exhibits 129: Xeris Biopharma Holdings Inc. - Key offerings
Exhibits 130: Inclusions checklist
Exhibits 131: Exclusions checklist
Exhibits 132: Currency conversion rates for US$
Exhibits 133: Research methodology
Exhibits 134: Validation techniques employed for market sizing
Exhibits 135: Information sources
Exhibits 136: List of abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Corcept Therapeutics Inc.
Perrigo Co. Plc
Recordati S.p.A
Xeris Biopharma Holdings Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2443EUR$2,500USD£2,039GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3908EUR$4,000USD£3,263GBP

The cushing syndrome market is segmented as below:

By Type

By Distribution Channel

By Geographical Landscape

The report on the cushing syndrome market covers the following areas:

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Cushing's Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Cushing's Syndrome - Market Insight, Epidemiology and Market Forecast - 2034

Human Growth Hormone Market 2024-2028

Male Hypogonadism Market 2024-2028